Lebrikizumab Biosimilar - Ultra Low Endotoxin

Lebrikizumab Biosimilar - Ultra Low Endotoxin, Human IgG4 S228P Kappa

Target: IL-13

Specificity: Detects human IL-13. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Lebrikizumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration: 5mg/ml

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE

Endotoxin: ≤ 0.1 EU/mg as determined by the LAL method

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• Artikelnummer: ICH5058UL-10mg
• Hersteller: Ichorbio
• Hersteller Artikelnummer: ICH5058UL-10mg
• Verpackungseinheit: 10mg
• Mengeneinheit: STK
• Reaktivität: Human
• Klonalität: Monoclonal
• Methode: Functional Assay
• Isotyp: Human IgG4 S228P Kappa